Trial intelligence / Profile preview

Remifentanil versus fentanyl for analgesia and sedation in ventilated neonates and infants

2005-003516-29Phase 3Completed

Sponsor
University of Cologne
Start
Oct 2006
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of remifentanil, fentanyl and midazolam in None (2 arms), sponsored by University of Cologne. Primary endpoints: Duration of artificial ventilation after discontinuation of opioid infusion, Time to extubation after discontinuation of opioid infusion and 1 more. Started Oct 2006; status: completed.

02

Drugs

remifentanilfentanylmidazolam

Beyond the preview

Go deeper on 2005-003516-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003516-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call